NCT00073476 - A Study to Evaluate the Efficacy and Safety of CP-101,606 in Subjects With an Acute Stroke | Biotech Hunter

Enrollment

300

Participants

Timeline

Start Date

September 30, 2003

Study Completion Date

February 28, 2005

Conditions

Stroke

Interventions

DRUG

traxiprodil (CP-101,606)

Trial Locations (29)

1600

Pfizer Investigational Site, Lisbon

15706

Pfizer Investigational Site, Santiago de Compostela

18103

Pfizer Investigational Site, Allentown

19141

Pfizer Investigational Site, Philadelphia

23538

Pfizer Investigational Site, Lübeck

27100

Pfizer Investigational Site, Pavia

28007

Pfizer Investigational Site, Madrid

28034

Pfizer Investigational Site, Madrid

28144

Pfizer Investigational Site, Salisbury

30342

Pfizer Investigational Site, Atlanta

40202

Pfizer Investigational Site, Louisville

45406

Pfizer Investigational Site, Dayton

45408

Pfizer Investigational Site, Dayton

45409

Pfizer Investigational Site, Dayton

45415

Pfizer Investigational Site, Dayton

46804

Pfizer Investigational Site, Fort Wayne

46805

Pfizer Investigational Site, Fort Wayne

50009

Pfizer Investigational Site, Zaragoza

51014

Pfizer Investigational Site, Tartu

79106

Pfizer Investigational Site, Freiburg im Breisgau

91942

Pfizer Investigational Site, La Mesa

97616

Pfizer Investigational Site, Bad Neustadt an der Saale

169608

Pfizer Investigational Site, Singapore

308433

Pfizer Investigational Site, Singapore

04103

Pfizer Investigational Site, Leipzig

H-1021

Pfizer Investigational Site, Budapest

H-9023

Pfizer Investigational Site, Győr

06126

Pfizer Investigational Site, Perugia

Codex 3049

Pfizer Investigational Site, Coimbra